Aiting Yang

995 total citations
29 papers, 712 citations indexed

About

Aiting Yang is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Aiting Yang has authored 29 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 16 papers in Epidemiology and 11 papers in Molecular Biology. Recurrent topics in Aiting Yang's work include Liver physiology and pathology (18 papers), Liver Disease Diagnosis and Treatment (15 papers) and Microbial metabolism and enzyme function (6 papers). Aiting Yang is often cited by papers focused on Liver physiology and pathology (18 papers), Liver Disease Diagnosis and Treatment (15 papers) and Microbial metabolism and enzyme function (6 papers). Aiting Yang collaborates with scholars based in China, United States and Germany. Aiting Yang's co-authors include Hong You, Wei Chen, Jidong Jia, Xuzhen Yan, Detlef Schuppan, Yury Popov, Anjian Xu, Min Cong, Tianhui Liu and Wenshan Zhao and has published in prestigious journals such as PLoS ONE, Hepatology and The FASEB Journal.

In The Last Decade

Aiting Yang

28 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aiting Yang China 15 300 293 255 132 104 29 712
Carmen G. Tag Germany 15 399 1.3× 337 1.2× 317 1.2× 215 1.6× 135 1.3× 26 988
Daniel Caballero‐Díaz Spain 8 208 0.7× 295 1.0× 172 0.7× 93 0.7× 180 1.7× 9 706
S S Wang United States 5 404 1.3× 232 0.8× 232 0.9× 182 1.4× 106 1.0× 8 747
Hiroyuki Fuke Japan 14 299 1.0× 274 0.9× 225 0.9× 148 1.1× 110 1.1× 38 746
Thiago M. de Assuncao United States 13 425 1.4× 512 1.7× 400 1.6× 257 1.9× 92 0.9× 34 1.1k
Lishuai Qu China 19 304 1.0× 497 1.7× 376 1.5× 88 0.7× 106 1.0× 48 1.0k
Mitsuo Toyoda Japan 13 372 1.2× 205 0.7× 220 0.9× 152 1.2× 72 0.7× 31 684
Guoqiang Li China 17 208 0.7× 412 1.4× 205 0.8× 219 1.7× 90 0.9× 35 928
Victoria L. Gadd United Kingdom 14 415 1.4× 194 0.7× 490 1.9× 255 1.9× 65 0.6× 22 915
Leandi Krüger United States 13 337 1.1× 314 1.1× 307 1.2× 251 1.9× 88 0.8× 18 746

Countries citing papers authored by Aiting Yang

Since Specialization
Citations

This map shows the geographic impact of Aiting Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aiting Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aiting Yang more than expected).

Fields of papers citing papers by Aiting Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aiting Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aiting Yang. The network helps show where Aiting Yang may publish in the future.

Co-authorship network of co-authors of Aiting Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Aiting Yang. A scholar is included among the top collaborators of Aiting Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aiting Yang. Aiting Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Qingdong, Qi Wang, Hong Zhao, et al.. (2025). Fibulin-1 deficiency alleviates liver fibrosis by inhibiting hepatic stellate cell activation via the p38 MAPK pathway. Cellular and Molecular Life Sciences. 82(1). 192–192. 2 indexed citations
2.
Yan, Xuzhen, Qi Han, Li Hong, et al.. (2025). ITGA8 deficiency in hepatic stellate cells attenuates CCl4-Induced liver fibrosis via suppression of COL11A1. Biochemical and Biophysical Research Communications. 756. 151522–151522.
3.
Zhang, Ning, Congjun Li, Yameng Sun, et al.. (2025). Hepatic stellate cell-derived microfibrillar-associated protein 2 prevents liver fibrosis by regulating extracellular matrix and inflammation. Theranostics. 15(9). 4033–4053. 3 indexed citations
4.
Zhang, Ning, Xiaoning Wu, Yameng Sun, et al.. (2024). Targeting thrombospondin-2 retards liver fibrosis by inhibiting TLR4-FAK/TGF-β signaling. JHEP Reports. 6(3). 101014–101014. 8 indexed citations
5.
Han, Qi, Xuzhen Yan, Ning Zhang, et al.. (2023). Aryl hydrocarbon receptor attenuates cholestatic liver injury by regulating bile acid metabolism. Biochemical and Biophysical Research Communications. 682. 259–265. 2 indexed citations
6.
Chen, Wei, Yameng Sun, Shuyan Chen, et al.. (2023). Matrisome gene-based subclassification of patients with liver fibrosis identifies clinical and molecular heterogeneities. Hepatology. 78(4). 1118–1132. 15 indexed citations
7.
Yan, Xuzhen, Ning Zhang, Tao Huang, et al.. (2023). Selective inhibition of hepatic stellate cell and fibroblast-derived LOXL1 attenuates BDL- and Mdr2−/−-induced cholestatic liver fibrosis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 325(6). G608–G621. 4 indexed citations
8.
Yang, Aiting, Xuzhen Yan, Hiroyuki Abé, et al.. (2022). Fibroblast Activation Protein Activates Macrophages and Promotes Parenchymal Liver Inflammation and Fibrosis. Cellular and Molecular Gastroenterology and Hepatology. 15(4). 841–867. 70 indexed citations
9.
Yang, Aiting, Xuzhen Yan, Xu Fan, et al.. (2021). Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice. Hepatology International. 15(5). 1122–1135. 27 indexed citations
10.
Yang, Aiting, Xuzhen Yan, Hufeng Xu, et al.. (2021). Selective depletion of hepatic stellate cells‐specific LOXL1 alleviates liver fibrosis. The FASEB Journal. 35(10). e21918–e21918. 21 indexed citations
11.
Chen, Wei, Aiting Yang, Jidong Jia, et al.. (2020). Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis. Hepatology. 72(2). 729–741. 181 indexed citations
12.
Zhao, Wenshan, Aiting Yang, Wei Chen, et al.. (2018). Inhibition of lysyl oxidase-like 1 (LOXL1) expression arrests liver fibrosis progression in cirrhosis by reducing elastin crosslinking. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(4). 1129–1137. 68 indexed citations
13.
Xu, Anjian, Yanmeng Li, Wenshan Zhao, et al.. (2017). PHP14 regulates hepatic stellate cells migration in liver fibrosis via mediating TGF-β1 signaling to PI3Kγ/AKT/Rac1 pathway. Journal of Molecular Medicine. 96(2). 119–133. 26 indexed citations
14.
Chen, Wei, Wenshan Zhao, Aiting Yang, et al.. (2017). Integrated analysis of microRNA and gene expression profiles reveals a functional regulatory module associated with liver fibrosis. Gene. 636. 87–95. 43 indexed citations
15.
Xu, Yang, Xiaoning Wu, Yiwen Shi, et al.. (2015). Baseline Hepatitis B Virus DNA Level is a Promising Factor for Predicting the 3rd Month Virological Response to Entecavir Therapy. Chinese Medical Journal. 128(14). 1867–1872. 5 indexed citations
16.
Yang, Aiting, Ping Wang, Min Cong, et al.. (2015). TGF‐β1 Induces the Dual Regulation of Hepatic Progenitor Cells with Both Anti‐ and Proliver Fibrosis. Stem Cells International. 2016(1). 1492694–1492694. 19 indexed citations
17.
Piao, Hongxin, Aiting Yang, Yameng Sun, et al.. (2014). Increasing Newly Diagnosed Rate and Changing Risk Factors of HCV in Yanbian Prefecture, a High Endemic Area in China. PLoS ONE. 9(1). e86190–e86190. 10 indexed citations
18.
Yang, Aiting, Ping Wang, Min Cong, et al.. (2013). Connective tissue growth factor induces hepatic progenitor cells to differentiate into hepatocytes. International Journal of Molecular Medicine. 32(1). 35–42. 10 indexed citations
19.
Cong, Min, Tianhui Liu, Ping Wang, et al.. (2013). Antifibrotic Effects of a Recombinant Adeno-Associated Virus Carrying Small Interfering RNA Targeting TIMP-1 in Rat Liver Fibrosis. American Journal Of Pathology. 182(5). 1607–1616. 37 indexed citations
20.
Wang, Ping, Min Cong, Tianhui Liu, et al.. (2010). Primary isolated hepatic oval cells maintain progenitor cell phenotypes after two-year prolonged cultivation. Journal of Hepatology. 53(5). 863–871. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmen G. Tag Breakdown of academic impact, for papers by Daniel Caballero‐Díaz Breakdown of academic impact, for papers by S S Wang Breakdown of academic impact, for papers by Hiroyuki Fuke Breakdown of academic impact, for papers by Thiago M. de Assuncao Breakdown of academic impact, for papers by Lishuai Qu Breakdown of academic impact, for papers by Mitsuo Toyoda Breakdown of academic impact, for papers by Guoqiang Li Breakdown of academic impact, for papers by Victoria L. Gadd Breakdown of academic impact, for papers by Leandi Krüger
Rankless by CCL
2026